Amarin Corp Ads (AMRN)
$20.78 0.05 (0.22%)
14:46 EST AMRN Stock Quote Delayed 15 Minutes
Previous Close $20.82
Market Cap 6.10B
PE Ratio -
Volume (Avg. Vol.) 3.59M
Day's Range 20.34 - 20.83
52-Week Range 13.76 - 26.12
Dividend & Yield N/A (N/A)
AMRN Stock Predictions, Articles, and Amarin Corp Ads News
- From InvestorPlace
- From the Web
Short sellers have targeted AMRN and the Amarin stock price is quite undervalued, making the shares quite attractive for long-term investors.
What does the FDA's recent approval of Vascepa mean for Amarin stock? Is the company really a target for buyout offers?
Amarin is targeting a huge market, and its main drug -- Vascepa -- is likely to be expanded in its coverage. Here’s a look at what’s ahead for the stock.
Although Amarin stock could potentially skyrocket off the pharmaceutical’s flagship drug Vascepa, approval challenges make this play incredibly risky.
Thanks to the effective cardiovascular drug Vascepa, Amarin stock has enjoyed an outsized performance so far this year. However, over the horizon stands big pharmaceutical competitors that are ready to spoil the party.
Amarin's Vascepa drug should be approved for expanded use soon. This should boost Amarin stock, which makes AMRN a solid buy right now.
Amarin stock is set to move higher on a potential label expansion. But does this mean that the drug will perform well in the market?
Options trading was heating up in Amarin, Disney and Facebook stock on Tuesday. Here’s what the data suggests moving forward.
Investors are looking for the stocks that have the potential to lift their portfolios to new heights. These investments are the stocks with the strongest long-term growth narratives, capable of delivering massive returns.
Amarin, iRobot, Canopy Growth, AMC Entertainment and American Airlines were our top stock trades on Wednesday.
Uncertainty is a constant risks for biotech stocks. Which ones matter? Some are down so much investors cannot ignore them now.
These 10 stocks, including SHOP stock, have been among the best stocks in the market over the past year. Where do they go from here?
Looking for stocks to buy now? These seven companies are among the best stocks to invest in for their immaculate record from the Street's top analysts. Here's why:
The stock charts of CVS Health, Pfizer and Weyerhaeuser head into the midpoint of the week on the verge of major moves.
Nike, Amarin, Goldman Sachs, Nio and Kroger are our top stock trades after seeing Tuesday's action. Lee what we're watching ahead of the open.
From Market News Video
Investors in Amarin Corp plc (AMRN) saw new options become available today, for the March 6th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMRN options chain for the new March 6th contracts and identified one put and one call contract of particular interest.
From The Motley Fool
Navellier RatingsPowered by Portfolio Grader